Global Automated Cell Culture Market is expected to register a CAGR of 8.18% during the forecast period and expected to hit USD 16,287.9 Million by 2027.

Automated cell culture is a process in which the growth and maintenance of cell culture are taken with advanced techniques. Cell culture is a process of removing the cells from the source to grow under the specified technical environment outward of the natural environment. Automated cell culture performs the steps involved in growing and maintaining the cell culture system. Traditionally, cell culture has been a manual process that requires many hours of repetitive, painstaking work to maintain absolute sterility. The automation in the steps involved in cell culture has several advantages, such as reducing time and saving labor costs. Automation ensures consistency of the procedure and provides sterility that even the best technicians cannot attain. Automated cell culture systems are easy to operate and capable of handling large volumes of culture as scale-up is quicker with automated systems.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/767

Factors that drive the market growth are fewer errors, lower contamination, and decreased human efforts. An increase in demand for research on regenerative medicines and stem cells is also one of the factors for growth apart for the rising number of patients suffering from neurological disorders. Additionally, the key players adopting the strategy of bringing in acquisition for expanded geographical reach as well as optimization of operational costs are also driving the growth of the automated cell culture market. However, the unavailability of skilled workforce is posing as a challenge for the growth of the market.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Automated Cell Culture Market— Tecan Trading AG, Siemens Healthcare GmbH, Hitachi, Ltd, Thermo Fisher Scientific, Sartorius Stedim Biotech Group, Hamilton Company, Beckman Coulter, Inc., F. Hoffmann-La Roche, Becton, Dickinson and Company and Others.

Segment Analysis

The global automated cell culture market has been segmented based on type, product, application, and end-user.

The market, based on type, has been segregated into modular automation and whole lab automation.
Based on product, the automated cell culture market has been divided into consumables and vessels.
Based on application, the automated cell culture market is segregated into biopharmaceutical production, tissue engineering & regenerative medicine, drug screening and development, gene therapy, stem cell research, diagnostics, toxicity testing, and others.
Regional Analysis

The global automated cell culture market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas are likely to hold the largest share of the global automated cell culture market during the assessment period owing to the presence of a large number of manufacturers of automated cell culture in the region. Some of the renowned automated cell culture manufacturers in the region include Thermo Fisher Scientific Inc., Hamilton Company, Beckman Coulter, Inc., Becton, Dickinson, and Company, and others. Within the U.S., the National Institutes of Health (NIH) had a budget of an estimated USD 1.495 billion into stem cell research projects in 2016, spanning a wide range of fields from cell biology to electrical engineering. The availability of key manufacturers and huge funding for research projects is expected to fuel the automated cell culture market in the region.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/automated-cell-culture-market-767

The automated cell culture market in Europe is expected to propel during the forecast period, owing to factors such as rising government initiatives, increasing product launch, and the convenience associated with the refined features of these products. Major biopharmaceutical companies are focusing on conducting clinical trial research in Asian countries due to the availability of highly skilled professionals and easy patient recruitment to conduct clinical experiments. This is resulting in a rising number of research laboratories in the region. These increasing number of research laboratories along with rising demand for novel therapies is expected to propel the market growth. The automated cell culture market in the Middle East & Africa is expected to witness a modest market growth rate from 2020 to 2027.